Literature DB >> 16934860

Clinical utility of HPV genotyping.

Chris J Meijer1, Peter J Snijders, Philip E Castle.   

Abstract

Mesh：

Year:  2006        PMID： 16934860     DOI： 10.1016/j.ygyno.2006.07.031

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN： 0090-8258            Impact factor:   5.482


× No keyword cloud information.
  25 in total

1.  High-grade cervical lesions among women attending a reference clinic in Brazil: associated factors and comparison among screening methods.

Authors:  Neide T Boldrini; Luciana B Freitas; Amanda R Coutinho; Flavia Z Loureiro; Liliana C Spano; Angélica E Miranda
Journal:  PLoS One       Date:  2014-07-11       Impact factor: 3.240

2.  Clinical experience with the Cervista HPV HR assay: correlation of cytology and HPV status from 56,501 specimens.

Authors:  Kenneth E Youens; Gregory A Hosler; Paula J Washington; E Patrick Jenevein; Kathleen M Murphy
Journal:  J Mol Diagn       Date:  2011-03       Impact factor: 5.568

3.  Concurrence of multiple human papillomavirus infections in a large US population-based cohort.

Authors:  Zihua Yang; Jack Cuzick; William C Hunt; Cosette M Wheeler
Journal:  Am J Epidemiol       Date:  2014-10-29       Impact factor: 4.897

4.  Prevalence of human papillomavirus in university young women.

Authors:  Maria T Montalvo; Ismelda Lobato; Hilda Villanueva; Celia Borquez; Daniela Navarrete; Juan Abarca; Gloria M Calaf
Journal:  Oncol Lett       Date:  2011-04-06       Impact factor: 2.967

5.  Prevalence of various human papillomavirus (HPV) genotypes among women who subjected to routine Pap smear test in Bushehr city (south west of Iran) 2008-2009.

Authors:  Keivan Zandi; Seyed Sajjad Eghbali; Rasool Hamkar; Shahnaz Ahmadi; Elissa Ramedani; Iman Deilami; Heidar Aziz Nejad; Fatemeh Farshadpour; Zahra Rastian
Journal:  Virol J       Date:  2010-03-22       Impact factor: 4.099

6.  Confirmatory real-time PCR assay for human papillomavirus (HPV) type 52 infection in anogenital specimens screened for HPV infection with the linear array HPV genotyping test.

Authors:  François Coutlée; Danielle Rouleau; Georges Ghattas; Catherine Hankins; Sylvie Vézina; Pierre Coté; John Macleod; Alexandra de Pokomandy; Deborah Money; Sharon Walmsley; Hélène Voyer; Paul Brassard; Eduardo Franco
Journal:  J Clin Microbiol       Date:  2007-09-26       Impact factor: 5.948

7.  [Cervical cancer screening: past--present--future].

Authors:  G Breitenecker
Journal:  Pathologe       Date:  2009-12       Impact factor: 1.011

8.  Validation of the SPF10 LiPA human papillomavirus typing assay using formalin-fixed paraffin-embedded cervical biopsy samples.

Authors:  Barbara Dal Bello; Arsenio Spinillo; Paola Alberizzi; Stefania Cesari; Barbara Gardella; Enrico Maria Silini
Journal:  J Clin Microbiol       Date:  2009-05-27       Impact factor: 5.948

9.  Evaluation of careHPV, Cervista Human Papillomavirus, and Hybrid Capture 2 Methods in Diagnosing Cervical Intraepithelial Neoplasia Grade 2+ in Xinjiang Uyghur Women.

Authors:  Gulixian Tuerxun; Awaguli Yukesaier; Ling Lu; Kailibinuer Aierken; Patiman Mijiti; Yujie Jiang; Axianguli Abulizi; Yuanyuan Zhang; Guzhanuer Abuduxikuer; Guzhalinuer Abulizi; Hua Li
Journal:  Oncologist       Date:  2016-06-17

10.  Clinical evaluation of a GP5+/6+-based luminex assay having full high-risk human papillomavirus genotyping capability and an internal control.

Authors:  D T Geraets; K Cuschieri; M N C de Koning; L J van Doorn; P J F Snijders; C J L M Meijer; W G V Quint; M Arbyn
Journal:  J Clin Microbiol       Date:  2014-09-10       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.